Synergizing structure and function: Cinnamoyl hydroxamic acids as potent urease inhibitors

Area of Science:

• Medicinal Chemistry
• Enzyme Inhibition
• Molecular Design

Background:

• Urease is a critical enzyme implicated in various pathological conditions.
• Developing effective urease inhibitors is a significant therapeutic goal.
• Hydroxamic acids and Michael acceptors are known pharmacophores with potential biological activities.

Purpose of the Study:

• To design, synthesize, and evaluate novel molecular hybrids for urease inhibition.
• To explore the structure-activity relationships of these hybrids.
• To elucidate the mechanism of urease inhibition.

Main Methods:

• Synthesis of molecular hybrids incorporating hydroxamic acid and Michael acceptor moieties.
• In vitro evaluation of urease inhibitory activity using IC50 determination.
• Kinetic studies to determine the mode of inhibition (e.g., mixed, competitive, non-competitive).
• Biophysical and theoretical studies to understand binding interactions.

Main Results:

• Synthesized compounds demonstrated potent urease inhibition with IC50 values between 3.8-12.8 µM.
• Most hybrids acted as mixed-type inhibitors.
• Compounds with electron-withdrawing groups on the aromatic ring exhibited enhanced activity.
• Hydroxamic acid core targets the active site, while the Michael acceptor binds to allosteric sites.

Conclusions:

• Novel molecular hybrids of hydroxamic acids and Michael acceptors are effective urease inhibitors.
• Electrophilicity of the Michael acceptor moiety is crucial for antiureolytic activity.
• The dual binding mode (active and allosteric sites) contributes to potent inhibition.